Science Explorer Back to mapMap
Discussion
Research facility · 's-Hertogenbosch · Netherlands

Netherlands Pharmacovigilance Centre Lareb

In research, Netherlands Pharmacovigilance Centre Lareb stands highest in Health Sciences (#9,429 of 16,688 worldwide) and Medicine (#8,382 of 14,558 worldwide), over all time.

lareb.nlROR OpenAlex
World rank, 2022-now
#20,707
of 22,385 · #24,179 all time
Rank in Netherlands
#189
of 197
Research works
316
▲ 48% vs 2018-21
Citations
5.1k
16.2 per fractional work
Top-10% rate
10.3%
all institutions 10.0%
vs its own fields
1.01×
1.00× is exactly expected
Open access
49%
world 40%
International
27%
world 18%
Netherlands Pharmacovigilance Centre Lareb

What is Netherlands Pharmacovigilance Centre Lareb known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #9,429 of 16,688 9.3%187
MedicineField #8,382 of 14,558 9.4%175

Each strip is that field's whole ranked pool, with the notch where Netherlands Pharmacovigilance Centre Lareb sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Netherlands Pharmacovigilance Centre Lareb work in?

In 2022-now, 62% of research at Netherlands Pharmacovigilance Centre Lareb is in Health Sciences, 25% in Life Sciences. Its largest fields are Medicine (58%), Pharmacology, Toxicology and Pharmaceutics (12%), Immunology and Microbiology (7%). It does 2.5× the world's share of Health Sciences.

Health Sciences: 55 fractional works · 62.4% of its workMedicine: 52 fractional works · 58.3% of its workPublic Health, Environmental and Occupational Health: 9 fractional works · 10.1% of its workInfectious Diseases: 6 fractional works · 6.4% of its workEpidemiology: 5 fractional works · 5.2% of its workPharmacology: 4 fractional works · 4.1% of its workPediatrics, Perinatology and Child Health: 3 fractional works · 3.9% of its workSurgery: 3 fractional works · 3.5% of its workObstetrics and Gynecology: 2 fractional works · 2.7% of its workRheumatology: 2 fractional works · 2.1% of its workGenetics: 2 fractional works · 1.8% of its workNeurology: 2 fractional works · 1.8% of its workOncology: 1 fractional works · 1.7% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.6% of its workEmergency Medicine: 1 fractional works · 1.4% of its workPsychiatry and Mental health: 1 fractional works · 1.4% of its workDermatology: 1 fractional works · 1.3% of its workGeriatrics and Gerontology: 1 fractional works · 1.3% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 1.3% of its workPhysiology: 1 fractional works · 1.0% of its workImmunology and Allergy: 1 fractional works · 0.8% of its workComplementary and alternative medicine: 1 fractional works · 0.7% of its workPathology and Forensic Medicine: 0 fractional works · 0.6% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.5% of its workHematology: 0 fractional works · 0.4% of its workHepatology: 0 fractional works · 0.4% of its workInternal Medicine: 0 fractional works · 0.4% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.4% of its workReproductive Medicine: 0 fractional works · 0.3% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.3% of its workOphthalmology: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.6% of its workHealth Professions: 3 fractional works · 3.3% of its workGeneral Health Professions: 1 fractional works · 1.2% of its workEmergency Medical Services: 0 fractional works · 0.5% of its workHealth Information Management: 0 fractional works · 0.4% of its workMedical Terminology: 0 fractional works · 0.4% of its workSpeech and Hearing: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.4% of its workNursing: 1 fractional works · 0.6% of its workNutrition and Dietetics: 1 fractional works · 0.6% of its workDentistry: 0 fractional works · 0.2% of its workLife Sciences: 22 fractional works · 24.8% of its workPharmacology, Toxicology and Pharmaceutics: 11 fractional works · 12.2% of its workToxicology: 9 fractional works · 10.4% of its workPharmacology: 2 fractional works · 1.8% of its workImmunology and Microbiology: 6 fractional works · 6.9% of its workImmunology: 2 fractional works · 2.8% of its workMicrobiology: 2 fractional works · 2.0% of its workApplied Microbiology and Biotechnology: 2 fractional works · 1.7% of its workVirology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 3.0% of its workMolecular Biology: 1 fractional works · 1.4% of its workEndocrinology: 1 fractional works · 1.0% of its workGenetics: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 2 fractional works · 2.5% of its workPlant Science: 1 fractional works · 1.4% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.5% of its workInsect Science: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.3% of its workNeuroscience: 0 fractional works · 0.3% of its workSocial Sciences: 6 fractional works · 7.0% of its workSocial Sciences: 3 fractional works · 3.6% of its workHealth: 3 fractional works · 3.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workDecision Sciences: 1 fractional works · 1.7% of its workStatistics, Probability and Uncertainty: 1 fractional works · 1.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPsychology: 1 fractional works · 1.0% of its workClinical Psychology: 0 fractional works · 0.5% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.5% of its workEconomics and Econometrics: 0 fractional works · 0.5% of its workBusiness, Management and Accounting: 0 fractional works · 0.1% of its workPhysical Sciences: 5 fractional works · 5.8% of its workEngineering: 1 fractional works · 1.4% of its workControl and Systems Engineering: 1 fractional works · 1.1% of its workSmaller subfields together: 0 fractional works · 0.3% of its workComputer Science: 1 fractional works · 1.4% of its workComputational Theory and Mathematics: 1 fractional works · 0.9% of its workArtificial Intelligence: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMathematics: 1 fractional works · 1.3% of its workStatistics and Probability: 1 fractional works · 1.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEarth and Planetary Sciences: 0 fractional works · 0.4% of its workAtmospheric Science: 0 fractional works · 0.4% of its workEnergy: 0 fractional works · 0.4% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.4% of its workEnvironmental Science: 0 fractional works · 0.4% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 0.3% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workChemistry: 0 fractional works · 0.3% of its workALL ITS WORKNetherlandsPharmacovigilanc…88fractional works, 2022-now
Life Sciences25%Physical Sciences6%Health Sciences62%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Medicine5258.3%
    2. Health Professions33.3%
    3. Nursing10.6%
    4. Dentistry00.2%
    1. Pharmacology, Toxicology and Pharmaceutics1112.2%
    2. Immunology and Microbiology66.9%
    3. Biochemistry, Genetics and Molecular Biology33.0%
    4. Agricultural and Biological Sciences22.5%
    5. Neuroscience00.3%
    1. Social Sciences33.6%
    2. Decision Sciences11.7%
    3. Psychology11.0%
    4. Economics, Econometrics and Finance00.5%
    5. Business, Management and Accounting00.1%
    1. Engineering11.4%
    2. Computer Science11.4%
    3. Mathematics11.3%
    4. Earth and Planetary Sciences00.4%
    5. Energy00.4%
    6. Environmental Science00.4%
    7. Materials Science00.3%
    8. Chemistry00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.53× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.56× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 6.86× its world share, 6 worksImmunology and Micro…Neuroscience: 0.16× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 34.50× its world share, 11 worksPharmacology, Toxico…Chemistry: 0.18× its world share, 0 worksChemistryComputer Science: 0.17× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 0.24× its world share, 0 worksEarth and Planetary …Energy: 0.41× its world share, 0 worksEnergyEngineering: 0.10× its world share, 1 worksEngineeringEnvironmental Science: 0.07× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.08× its world share, 0 worksMaterials ScienceMathematics: 1.14× its world share, 1 worksMathematicsDentistry: 0.39× its world share, 0 worksDentistryHealth Professions: 1.25× its world share, 3 worksHealth ProfessionsMedicine: 3.03× its world share, 52 worksMedicineNursing: 1.26× its world share, 0 worksNursingBusiness, Management and Accounting: 0.04× its world share, 0 worksBusiness, Management…Decision Sciences: 1.71× its world share, 2 worksDecision SciencesEconomics, Econometrics and Finance: 0.26× its world share, 0 worksEconomics, Econometr…Psychology: 0.34× its world share, 1 worksPsychologySocial Sciences: 0.28× its world share, 3 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 34.5×. Every wedge is a field page.

All 22 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics34.50×11 works
  2. Immunology and Microbiology6.86×6 works
  3. Medicine3.03×52 works
  4. Decision Sciences1.71×2 works
  5. Nursing1.26×0 works
  6. Health Professions1.25×3 works
  7. Mathematics1.14×1 works
  8. Biochemistry, Genetics and Molecular Biology0.56×3 works
  9. Agricultural and Biological Sciences0.53×2 works
  10. Energy0.41×0 works
  11. Dentistry0.39×0 works
  12. Psychology0.34×1 works
  13. Social Sciences0.28×3 works
  14. Economics, Econometrics and Finance0.26×0 works
  15. Earth and Planetary Sciences0.24×0 works
  16. Chemistry0.18×0 works
  17. Computer Science0.17×1 works
  18. Neuroscience0.16×0 works
  19. Engineering0.10×1 works
  20. Materials Science0.08×0 works
  21. Environmental Science0.07×0 works
  22. Business, Management and Accounting0.04×0 works

Who are the top researchers at Netherlands Pharmacovigilance Centre Lareb?

Ranked on the quality score, Anneke Passier, Agnes C Kant and Kees van Grootheest lead among researchers whose main affiliation is Netherlands Pharmacovigilance Centre Lareb.

  1. 1 Anneke Passier Netherlands · #1,308,868 worldwide 1.7k citations · 46 works
  2. 2 Agnes C Kant Netherlands · #1,378,935 worldwide 3.2k citations · 102 works
  3. 3 Kees van Grootheest Netherlands · #1,424,736 worldwide 2.1k citations · 63 works
  4. 4 Linda Härmark Netherlands · #1,788,694 worldwide 2k citations · 84 works
  5. 5 Corine Ekhart Netherlands · #1,810,003 worldwide 1.1k citations · 42 works
  6. 6 Florence P. A. M. van Hunsel Netherlands · #2,069,227 worldwide 3.4k citations · 180 works
  7. 7 Leàn Rolfes Netherlands · #2,308,022 worldwide 587 citations · 33 works
  8. 8 Leontine van Balveren Netherlands · #2,438,186 worldwide 161 citations · 15 works
  9. 9 Joep H. G. Scholl Netherlands · #3,022,406 worldwide 401 citations · 29 works
  10. 10 Saskia Vorstenbosch Netherlands · #3,074,968 worldwide 265 citations · 23 works
All ranked researchers at Netherlands Pharmacovigilance Centre Lareb

What are the most cited papers from Netherlands Pharmacovigilance Centre Lareb?

The most cited paper from Netherlands Pharmacovigilance Centre Lareb is "A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions" (Eugène van Puijenbroek, Andrew M. Bate, Hubert G.M. Leufkens et al., 2002), with 1,385 citations. Next come "Medication use in pregnancy: a cross-sectional, multinational web-based study" (512) and "The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration" (332).

Most cited papers
#PaperReleasedCitations
1 A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions Eugène van Puijenbroek, Andrew M. Bate, Hubert G.M. Leufkens et al. · Pharmacoepidemiology and Drug Safety 2002 1,385
2 Medication use in pregnancy: a cross-sectional, multinational web-based study Angela Lupattelli, Olav Spigset, Michael James Twigg et al. · BMJ Open Open access Feb 2014 512
3 The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration Michele Fusaroli et al. · Drug Safety Open access 7 May 2024 332
4 Pharmacovigilance: methods, recent developments and future perspectives Linda Härmark, A.C. van Grootheest · European Journal of Clinical Pharmacology 3 Jun 2008 297
5 Attitudinal survey of voluntary reporting of adverse drug reactions Eland, Belton, van Adrianus Grootheest et al. · British Journal of Clinical Pharmacology Open access Oct 1999 257
All 59 most cited papers, with filters and sorting

Which keywords describe research at Netherlands Pharmacovigilance Centre Lareb?

By fractional works in 2022-now, weighted toward what it does more of than the world: Adverse Drug Reactions, Pharmacovigilance, Signal Detection, Epidemiology, Vaccine, SARS-CoV-2, Pregnancy and Pandemic.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology11▲ 3.2×38 topics
  2. Adverse Drug Reactions10▲ 217×2 topics
  3. Pharmacovigilance9▲ 605×1 topic
  4. Signal Detection9▲ 605×1 topic
  5. Vaccine7▲ 20×8 topics
  6. SARS-CoV-27▲ 25×4 topics
  7. Pandemic6▲ 7.0×6 topics
  8. Pregnancy6▲ 32×5 topics
  9. Immunity6▲ 16×2 topics
  10. Coronavirus5▲ 27×2 topics
  11. Pathogenesis5▲ 10×12 topics
  12. ACE2 Receptor5▲ 23×3 topics
  13. Rheumatoid Arthritis4▲ 52×2 topics
  14. Teratogenicity4▲ 96×2 topics
  15. Viral Transmission4▲ 35×2 topics
  16. Fertility4▲ 51×2 topics
  17. antibody4▲ 45×1 topic
  18. spike protein4▲ 45×1 topic
  19. COVID-194▲ 3.2×8 topics
  20. Inflammatory Bowel Disease4▲ 35×1 topic
  21. Medication Use4▲ 171×1 topic
  22. COVID-19 Vaccine3▲ 55×2 topics
  23. Diagnosis3▲ 4.1×13 topics
  24. Treatment3▲ 3.1×15 topics
  25. Risk Perception3▲ 13×2 topics
  26. Child Development3▲ 8.2×2 topics
  27. Maternal Mortality3▲ 15×5 topics
  28. HLA-B*57013▲ 165×1 topic
  29. Health Behavior3▲ 34×1 topic
  30. Stevens-Johnson Syndrome3▲ 165×1 topic
  31. Vaccine Hesitancy3▲ 51×1 topic
  32. Thrombosis3▲ 11×4 topics
  33. Drug Resistance2▲ 9.6×4 topics
  34. Psychological Interventions2▲ 17×3 topics
  35. Maternal Mental Health2▲ 41×1 topic
  36. Maternal Outcomes2▲ 29×2 topics
  37. Neonatal Infection2▲ 61×1 topic
  38. Perinatal Depression2▲ 41×1 topic
  39. Perinatal Outcomes2▲ 29×2 topics
  40. Vertical Transmission2▲ 61×1 topic

Which research topics does Netherlands Pharmacovigilance Centre Lareb publish most on?

By volume in 2022-now: Pharmacovigilance and Adverse Drug Reactions, SARS-CoV-2 and COVID-19 Research, Pregnancy and Medication Impact and Vaccine Coverage and Hesitancy.

Pharmacovigilance and Ad…9Pharmacovigilance and Adverse Drug Reactions: 9 fractional worksSARS-CoV-2 and COVID-19 …4SARS-CoV-2 and COVID-19 Research: 4 fractional worksPregnancy and Medication…4Pregnancy and Medication Impact: 4 fractional worksVaccine Coverage and Hesitancy: 3 fractional worksDrug-Induced Adverse Reactions: 3 fractional worksCOVID-19 Impact on Repro…2COVID-19 Impact on Reproduction: 2 fractional worksMaternal Mental Health During Pregnancy and Postpartum: 2 fractional worksBacterial Infections and Vaccines: 2 fractional worksAntibiotic Use and Resistance: 2 fractional worksPharmaceutical Quality and Counterfeiting: 1 fractional works
ToxicologyInfectious DiseasesPublic Health, Environmental and Occupational HealthHealth4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Pharmacovigilance and Adverse Drug Reactions Toxicology 9 works
  2. 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 4 works
  3. 3 Pregnancy and Medication Impact Public Health, Environmental and Occupational Health 4 works
  4. 4 Vaccine Coverage and Hesitancy Health 3 works
  5. 5 Drug-Induced Adverse Reactions Pharmacology 3 works
  6. 6 COVID-19 Impact on Reproduction Obstetrics and Gynecology 2 works
  7. 7 Maternal Mental Health During Pregnancy and Postpartum Public Health, Environmental and Occupational Health 2 works
  8. 8 Bacterial Infections and Vaccines Microbiology 2 works
  9. 9 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 2 works
  10. 10 Pharmaceutical Quality and Counterfeiting Public Health, Environmental and Occupational Health 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available48.6%not open51.4%

World: 40% of research is openly available.

with international co-authors27.3%domestic only72.7%

World: 18% is written across borders.

How has Netherlands Pharmacovigilance Centre Lareb's research output changed?

Output in 2022-2025 was 48% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Netherlands Pharmacovigilance Centre Lareb as a percentage of every work published that year, 0.00021% in 2024.

still counting0.00025%0.00050%0.00075%Netherlands Pharmacovigilance Centre Lareb0.00033% in 20251990200020102020

Fractional works of Netherlands Pharmacovigilance Centre Lareb over all fractional works that year. How the balance of science has shifted.

Other research institutions in 's-Hertogenbosch

All research institutions in 's-Hertogenbosch

Share Netherlands Pharmacovigilance Centre Lareb's ranking

Netherlands Pharmacovigilance Centre Lareb on Science Explorer

A card with Netherlands Pharmacovigilance Centre Lareb's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Netherlands Pharmacovigilance Centre Lareb. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.